XI — Precision Medicine
This edition explored the emerging field of precision medicine, where treatments are tailored to individual genetic profiles, promising more effective and personalized healthcare.
Key Themes
Building on the genomic revolution explored in earlier editions, this conference examined the emerging paradigm of precision medicine, where treatments are tailored to individual patients based on their genetic profiles, lifestyle, and environment. Oncologists, geneticists, and bioinformaticians presented the state of the art.
Pier Giuseppe Pelicci discussed how molecular profiling of tumors is enabling more targeted cancer therapies, reducing side effects and improving outcomes. Other speakers explored the potential of liquid biopsies, pharmacogenomics, and AI-driven diagnostics to transform clinical practice.
The conference also addressed the challenges of implementing precision medicine at scale: the cost of genomic testing, the need for massive biobanks and data infrastructure, questions of data privacy, and the risk of widening health disparities between those who can access personalized treatments and those who cannot.